Herantis Pharma Oyj (HEL:HRTIS)

Finland flag Finland · Delayed Price · Currency is EUR
1.385
-0.015 (-1.07%)
Feb 21, 2025, 6:18 PM EET
-3.15%
Market Cap 27.92M
Revenue (ttm) n/a
Net Income (ttm) -612.16K
Shares Out 20.16M
EPS (ttm) -0.03
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,734
Average Volume 19,038
Open 1.445
Previous Close 1.400
Day's Range 1.380 - 1.445
52-Week Range 1.170 - 1.880
Beta 0.30
RSI 30.00
Earnings Date Mar 6, 2025

About Herantis Pharma Oyj

Herantis Pharma Oyj, a biotech company, engages in the development of disease-modifying cerebral dopamine neurotrophic factor (CDNF) based therapies for Parkinson’s disease (PD). Its lead product in pipeline includes HER-096, an advanced small synthetic chemical peptidomimetic molecule developed based on the active site of the CDNF protein for the treatment of PD and other neurodegenerative diseases. The company was incorporated in 2008 and is based in Espoo, Finland. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2008
Employees 10
Stock Exchange Nasdaq Helsinki
Ticker Symbol HRTIS
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.